Ulrika W. Nilsson

516 total citations
10 papers, 398 citations indexed

About

Ulrika W. Nilsson is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Ulrika W. Nilsson has authored 10 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Ulrika W. Nilsson's work include Estrogen and related hormone effects (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Ulrika W. Nilsson is often cited by papers focused on Estrogen and related hormone effects (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Ulrika W. Nilsson collaborates with scholars based in Sweden, Australia and United Kingdom. Ulrika W. Nilsson's co-authors include Charlotta Dabrosin, Stina Garvin, Annelie Abrahamsson, Stephen Tong, Bryan R.G. Williams, Fredrik Huss, Mark A. Behlke, Martha Lappas, Aaron T. Irving and Michael P. Gantier and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Ulrika W. Nilsson

10 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrika W. Nilsson Sweden 9 196 128 124 89 60 10 398
Domenico Zito Italy 8 164 0.8× 123 1.0× 111 0.9× 117 1.3× 78 1.3× 12 427
Hiroshi Toyoki Japan 16 251 1.3× 99 0.8× 161 1.3× 136 1.5× 87 1.4× 27 567
Brittney S. Harrington Australia 10 211 1.1× 87 0.7× 42 0.3× 132 1.5× 56 0.9× 19 393
Susanne Schüler Germany 14 219 1.1× 65 0.5× 132 1.1× 158 1.8× 47 0.8× 26 451
Zhengfeng Wang China 9 213 1.1× 82 0.6× 30 0.2× 89 1.0× 41 0.7× 17 392
Alma Contegiacomo Italy 13 192 1.0× 113 0.9× 115 0.9× 162 1.8× 27 0.5× 31 449
G. Pommier France 11 242 1.2× 97 0.8× 60 0.5× 92 1.0× 61 1.0× 24 465
Kimberly Malloy United States 9 371 1.9× 97 0.8× 51 0.4× 213 2.4× 44 0.7× 23 565
Laura M. Popoviciu United States 6 139 0.7× 87 0.7× 26 0.2× 92 1.0× 43 0.7× 6 333
Maciej Brązert Poland 15 285 1.5× 108 0.8× 53 0.4× 142 1.6× 87 1.4× 43 594

Countries citing papers authored by Ulrika W. Nilsson

Since Specialization
Citations

This map shows the geographic impact of Ulrika W. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika W. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika W. Nilsson more than expected).

Fields of papers citing papers by Ulrika W. Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrika W. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika W. Nilsson. The network helps show where Ulrika W. Nilsson may publish in the future.

Co-authorship network of co-authors of Ulrika W. Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrika W. Nilsson. A scholar is included among the top collaborators of Ulrika W. Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrika W. Nilsson. Ulrika W. Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Nilsson, Ulrika W., Terrance G. Johns, Tu’uhevaha J. Kaitu’u‐Lino, et al.. (2013). Effects of Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, on Human Placental Cell Growth. Obstetrics and Gynecology. 122(4). 737–744. 21 indexed citations
2.
Skubisz, Monika, Andrew W. Horne, Terrance G. Johns, et al.. (2013). Combination Gefitinib and Methotrexate Compared With Methotrexate Alone to Treat Ectopic Pregnancy. Obstetrics and Gynecology. 122(4). 745–751. 20 indexed citations
3.
Gantier, Michael P., Stephen Tong, Mark A. Behlke, et al.. (2010). Rational Design of Immunostimulatory siRNAs. Molecular Therapy. 18(4). 785–795. 56 indexed citations
4.
Nilsson, Ulrika W., Annelie Abrahamsson, & Charlotta Dabrosin. (2010). Angiogenin Regulation by Estradiol in Breast Tissue: Tamoxifen Inhibits Angiogenin Nuclear Translocation and Antiangiogenin Therapy Reduces Breast Cancer Growth In vivo. Clinical Cancer Research. 16(14). 3659–3669. 46 indexed citations
5.
Nilsson, Ulrika W., Terrance G. Johns, Yangyang Gao, et al.. (2010). 153. COMBINATION METHOTREXATE AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION AS A NOVEL MEDICATION-BASED CURE OF ECTOPIC PREGNANCIES. Reproduction Fertility and Development. 22(9). 71–71. 2 indexed citations
6.
7.
Garvin, Stina, Ulrika W. Nilsson, Fredrik Huss, Gunnar Kratz, & Charlotta Dabrosin. (2006). Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell and Tissue Research. 325(2). 245–251. 31 indexed citations
8.
Nilsson, Ulrika W. & Charlotta Dabrosin. (2006). Estradiol and Tamoxifen Regulate Endostatin Generation via Matrix Metalloproteinase Activity in Breast CancerIn vivo. Cancer Research. 66(9). 4789–4794. 46 indexed citations
9.
Nilsson, Ulrika W., Stina Garvin, & Charlotta Dabrosin. (2006). MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Research and Treatment. 102(3). 253–261. 78 indexed citations
10.
Garvin, Stina, Ulrika W. Nilsson, & Charlotta Dabrosin. (2005). Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. British Journal of Cancer. 93(9). 1005–1010. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Zito Breakdown of academic impact, for papers by Hiroshi Toyoki Breakdown of academic impact, for papers by Brittney S. Harrington Breakdown of academic impact, for papers by Susanne Schüler Breakdown of academic impact, for papers by Zhengfeng Wang Breakdown of academic impact, for papers by Alma Contegiacomo Breakdown of academic impact, for papers by G. Pommier Breakdown of academic impact, for papers by Kimberly Malloy Breakdown of academic impact, for papers by Laura M. Popoviciu Breakdown of academic impact, for papers by Maciej Brązert
Rankless by CCL
2026